|
1
|
Gonzalvez F and Ashkenazi A: New insights
into apoptosis signaling by Apo2L/TRAIL. Oncogene. 29:4752–4765.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aggarwal BB: Signalling pathways of the
TNF superfamily: A double-edged sword. Nat Rev Immunol. 3:745–756.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bellail AC, Tse MC, Song JH, Phuphanich S,
Olson JJ, Sun SY and Hao C: DR5-mediated DISC controls caspase-8
cleavage and initiation of apoptosis in human glioblastomas. J Cell
Mol Med. 14:1303–1317. 2010. View Article : Google Scholar :
|
|
4
|
Bellail AC, Qi L, Mulligan P, Chhabra V
and Hao C: TRAIL agonists on clinical trials for cancer therapy:
The promises and the challenges. Rev Recent Clin Trials. 4:34–41.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin CY, Park C, Hwang HJ, Kim GY, Choi BT,
Kim WJ and Choi YH: Naringenin up-regulates the expression of death
receptor 5 and enhances TRAIL-induced apoptosis in human lung
cancer A549 cells. Mol Nutr Food Res. 55:300–309. 2011. View Article : Google Scholar
|
|
6
|
Oyagbemi AA, Saba AB and Azeez OI:
Molecular targets of [6]-gingerol: Its potential roles in cancer
chemoprevention. Biofactors. 36:169–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shukla Y and Singh M: Cancer preventive
properties of ginger: A brief review. Food Chem Toxicol.
45:683–690. 2007. View Article : Google Scholar
|
|
8
|
Lee TY, Lee KC, Chen SY and Chang HH:
6-gingerol inhibits ROS and iNOS through the suppression of
PKC-alpha and NF-kappaB pathways in lipopolysaccharide-stimulated
mouse macrophages. Biochem Biophys Res Commun. 382:134–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bode AM, Ma WY, Surh YJ and Dong Z:
Inhibition of epidermal growth factor-induced cell transformation
and activator protein 1 activation by [6]-gingerol. Cancer Res.
61:850–853. 2001.PubMed/NCBI
|
|
10
|
Chakraborty D, Bishayee K, Ghosh S, Biswas
R, Mandal SK and Khuda-Bukhsh AR: [6]-gingerol induces caspase
3-dependent apoptosis and autophagy in cancer cells: Drug-DNA
interaction and expression of certain signal genes in HeLa cells.
Eur J Pharmacol. 694:20–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee E and Surh YJ: Induction of apoptosis
in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol.
Cancer Lett. 134:163–168. 1998. View Article : Google Scholar
|
|
12
|
Kroemer G, Mariño G and Levine B:
Autophagy and the integrated stress response. Mol Cell. 40:280–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mizushima N: Autophagy: process and
function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Klionsky DJ, Abeliovich H, Agostinis P,
Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA,
Ballabio A, et al: Guidelines for the use and interpretation of
assays for monitoring autophagy in higher eukaryotes. Autophagy.
4:151–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakatogawa H, Ichimura Y and Ohsumi Y:
Atg8, a ubiquitin-like protein required for autophagosome
formation, mediates membrane tethering and hemifusion. Cell.
130:165–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie Z, Nair U and Klionsky DJ: Atg8
controls phagophore expansion during autophagosome formation. Mol
Biol Cell. 19:3290–3298. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bjørkøy G, Lamark T, Brech A, Outzen H,
Perander M, Overvatn A, Stenmark H and Johansen T: p62/SQSTM1 forms
protein aggregates degraded by autophagy and has a protective
effect on huntingtin-induced cell death. J Cell Biol. 171:603–614.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mizushima N and Yoshimori T: How to
interpret LC3 immuno-blotting. Autophagy. 3:542–545. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livesey KM, Tang D, Zeh HJ and Lotze MT:
Autophagy inhibition in combination cancer treatment. Curr Opin
Investig Drugs. 10:1269–1279. 2009.PubMed/NCBI
|
|
20
|
Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu
Y, Xie M, Yin X, Livesey KM, Lotze MT, et al: HMGB1-induced
autophagy promotes chemotherapy resistance in leukemia cells.
Leukemia. 25:23–31. 2011. View Article : Google Scholar
|
|
21
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Apel A, Herr I, Schwarz H, Rodemann HP and
Mayer A: Blocked autophagy sensitizes resistant carcinoma cells to
radiation therapy. Cancer Res. 68:1485–1494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carew JS, Espitia CM, Esquivel JA II,
Mahalingam D, Kelly KR, Reddy G, Giles FJ and Nawrocki ST:
Lucanthone is a novel inhibitor of autophagy that induces cathepsin
D-mediated apoptosis. J Biol Chem. 286:6602–6613. 2011. View Article : Google Scholar :
|
|
24
|
Boya P, González-Polo RA, Casares N,
Perfettini JL, Dessen P, Larochette N, Métivier D, Meley D,
Souquere S, Yoshimori T, et al: Inhibition of macroautophagy
triggers apoptosis. Mol Cell Biol. 25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sotelo J, Briceño E and López-González MA:
Adding chloroquine to conventional treatment for glioblastoma
multiforme: A randomized, double-blind, placebo-controlled trial.
Ann Intern Med. 144:337–343. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goldberg SB, Supko JG, Neal JW, Muzikansky
A, Digumarthy S, Fidias P, Temel JS, Heist RS, Shaw AT, McCarthy
PO, et al: A phase I study of erlotinib and hydroxychloroquine in
advanced non-small-cell lung cancer. J Thorac Oncol. 7:1602–1608.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Poole B and Ohkuma S: Effect of weak bases
on the intralysosomal pH in mouse peritoneal macrophages. J Cell
Biol. 90:665–669. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fan C, Wang W, Zhao B, Zhang S and Miao J:
Chloroquine inhibits cell growth and induces cell death in A549
lung cancer cells. Bioorg Med Chem. 14:3218–3222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang PD, Zhao YL, Deng XQ, Mao YQ, Shi W,
Tang QQ, Li ZG, Zheng YZ, Yang SY and Wei YQ: Antitumor and
antimetastatic activities of chloroquine diphosphate in a murine
model of breast cancer. Biomed Pharmacother. 64:609–614. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoon YH, Cho KS, Hwang JJ, Lee SJ, Choi JA
and Koh JY: Induction of lysosomal dilatation, arrested autophagy,
and cell death by chloroquine in cultured ARPE-19 cells. Invest
Ophthalmol Vis Sci. 51:6030–6037. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mahalingam D, Szegezdi E, Keane M, de Jong
S and Samali A: TRAIL receptor signalling and modulation: Are we on
the right TRAIL? Cancer Treat Rev. 35:280–288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoshikawa M, Hatakeyama S, Chatani N,
Nishino Y and Yamahara J: Qualitative and quantitative analysis of
bioactive principles in Zingiberis Rhizoma by means of high
performance liquid chromatography and gas liquid chromatography. On
the evaluation of Zingiberis Rhizoma and chemical change of
constituents during Zingiberis Rhizoma processing. Yakugaku Zasshi.
113:307–315. 1993.In Japanese. PubMed/NCBI
|
|
33
|
Nakazawa T and Ohsawa K: Metabolism of
[6]-gingerol in rats. Life Sci. 70:2165–2175. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Habib SH, Makpol S, Abdul Hamid NA, Das S,
Ngah WZ and Yusof YA: Ginger extract (Zingiber officinale) has
anti-cancer and anti-inflammatory effects on ethionine-induced
hepatoma rats. Clinics (São Paulo). 63:807–813. 2008. View Article : Google Scholar
|
|
35
|
Singh K, Sharma A, Mir MC, Drazba JA,
Heston WD, Magi-Galluzzi C, Hansel D, Rubin BP, Klein EA and
Almasan A: Autophagic flux determines cell death and survival in
response to Apo2L/TRAIL (dulanermin). Mol Cancer. 13:702014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park KJ, Lee SH, Kim TI, Lee HW, Lee CH,
Kim EH, Jang JY, Choi KS, Kwon MH and Kim YS: A human scFv antibody
against TRAIL receptor 2 induces autophagic cell death in both
TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Res.
67:7327–7334. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ishiguro K, Ando T, Maeda O, Ohmiya N,
Niwa Y, Kadomatsu K and Goto H: Ginger ingredients reduce viability
of gastric cancer cells via distinct mechanisms. Biochem Biophys
Res Commun. 362:218–223. 2007. View Article : Google Scholar : PubMed/NCBI
|
